Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-sensitive recurrent ovarian cancer

Autor:	Loverix, L., Vanderstichele, A., Olbrecht, S., Van Niewenhuysen, E., Van Gorp, T., Han, S.N., Salihi, R., Concin, N., Neven, P., Busschaert, P., Lambrechts, D., Vergote, I.
Zdroj:	In Gynecologic Oncology October 2020 159 Supplement 1:17-18
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect